April 17, 2015

Infections spur new guidelines for endoscope reprocessing

By: OR Manager
Share

The Food and Drug Administration (FDA) on March 17 published a final guidance on reprocessing reusable medical devices. This guidance, which provides manufacturers with recommendations to validate their reprocessing instructions, comes on the heels of a host of “superbug” bacteria outbreaks related to reprocessing of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes.

The FDA will now require proof from manufacturers that new devices can be reprocessed reliably.

Until recently, companies could simply confirm to the FDA that their instructions for use (IFU) actually worked.

The FDA has received reports of 135 patients who may have been infected by contaminated endoscopes between January 2013 and December 2014. Contaminated ERCP duodenoscopes have been linked to superbug outbreaks in at least eight hospitals across the country.

The multidrug-resistant bacteria responsible for the outbreaks have been mostly a strain of carbapenem-resistant Enterobacteriaceae (CRE), which has a mortality rate of 40% or more.

 

Outbreaks not new

Some 20 million endoscopies are performed each year in the US, and more healthcare-associated infections have been linked to contaminated endoscopes than to any other medical device.

Lynne Thomas, BSN, RN, CGRN, CFER

Lynne Thomas, BSN, RN, CGRN, CFER

The cases now being reported are just the tip of the iceberg, notes Lynne Thomas, BSN, RN, CGRN, CFER, vice president of regulation and compliance, Integrated Medical Systems, Inc, Birmingham, Alabama. Information on some back to 2008 is just coming to light, but the infections may be difficult to link to endoscopes because documentation is not consistent, she says.

These outbreaks have been known for some time, says Cori L. Ofstead, MSPH, an epidemiologist who is president and CEO of Ofstead & Associates, Inc, St Paul, Minnesota. A large outbreak in Florida in 2009 with a very high mortality rate was in the scientific literature, but it did not receive the headlines the recent outbreaks have garnered.

When a 48-year-old woman died in November 2014 after she received treatment with a contaminated ERCP duodenoscope at Ronald Reagan UCLA Medical Center, Los Angeles, a lawyer filed a wrongful death lawsuit, and the media became involved.

Another lawsuit involves a high school student who became infected with a superbug after having a biliary stent inserted with an ERCP duodenoscope, also at Ronald Reagan UCLA Medical Center. After 3 months in the hospital, he had the stent removed with an ERCP duodenoscope, and he became infected again. He remains in the hospital.

In these cases there was a clear connection between contaminated duodenoscopes and infections.

 

Precleaning is key

The problems with endoscopes stem from their design, where they are used, and inadequate reprocessing. Typically, endoscopes are inserted into the body through an orifice that is naturally filled with microbial flora. Healthy people have more than 200 different microbes in their mouths and about a thousand different microbes in their intestines.

When an endoscope is inserted, it gets covered with microbes. Just 1 mL of fluid can contain 10 billion viable microbes. A gram of fecal residue, which is often left on a colonoscope, contains up to 100 billion bacteria. Reprocessing, therefore, starts with a very dirty instrument, says Ofstead. This is why precleaning immediately after use is important.

There are eight main steps and more than 130 substeps for endoscopy reprocessing. Precleaning immediately after use is the most crucial, says Thomas (sidebar below). It is key to the retardation of biofilm development and successful high-level disinfection or sterilization.

However, precleaning isn’t always done or isn’t always done correctly. A 2014 study by Ofstead and colleagues found that two out of three times, visible residue remained on endoscopes after precleaning. Rapid indicator tests found blood, protein, and adenosine triphosphate (ATP), an indicator of cellular activity. Even after manual cleaning in the reprocessing center, 9% still had blood, 27% still had protein, and 64% had ATP.

An investigation of severe infections in three men who had cystoscopy procedures found that the institution was doing no bedside precleaning, no leak testing, and no flushing of the channel with detergent after use. The manufacturer found residue and debris in the distal end of the cystoscope and biomaterial buildup in the insertion tubes, says Ofstead.

 

Changing practices

One of the confounding aspects of the present superbug outbreaks is that infections have occurred despite adherence to all reprocessing steps and guidelines. This is why the FDA, Centers for Disease Control and Prevention (CDC), AORN, and other organizations are reviewing and updating their device reprocessing standards, recommendations, and guidelines (sidebar below).

Some hospitals are taking extreme measures on their own to stop infections.

At Virginia Mason Hospital in Seattle, infection preventionists noticed they had a large group of patients with CRE; 11 had died. When they cultured their ERCP duodenoscopes, they found the pathogen that was implicated in the outbreak plus another multidrug-resistant pathogen.

Reprocessing was being done in accordance with guidelines, but four of their eight duodenoscopes contained these pathogens. In fact, says Ofstead, staff were going beyond the guidelines and using a magnifying glass to look at the tip of the duodenoscope. When they found residue on the tip, they used a stiff brush not described in the manufacturer’s IFU to clean it. They also used toothpicks to pry debris from the distal end of the duodenoscopes.

An assessment of the duodenoscopes by the manufacturer found cracks, frays, and damage in the channels. The hospital got rid of the eight duodenoscopes and bought 20 new ones at $37,000 each. In addition, reprocessing practices were changed so that each duodenoscope is cultured every time it’s used, and it’s quarantined for 48 hours. If a culture comes back positive, the duodenoscope is reprocessed. If it comes back positive again, the duodenoscope is sent back to the manufacturer for repair.

The changes so far have cost the hospital more than $1 million. Yet, despite the changes and rigorous attention to cleaning, 3% of their duodenoscopes are still contaminated after reprocessing.

In 2013, infection preventionists at suburban Chicago’s Advocate Lutheran General Hospital noticed patients were coming in with a very unusual infection caused by New Delhi metallo (NDM)-β-1-producing Escherichia coli.

At that time in the US, there had only been about 40 cases, and the hospital had six cases in just a few months.

An investigation found these patients all had procedures with an ERCP duodenoscope. The technicians were doing all of the reprocessing steps correctly, and cultures of the duodenoscope were negative. When infections continued to occur, the hospital notified the CDC. With the use of more advanced culturing techniques, the CDC’s cultures came back positive. Upon notification of the patients who had procedures with the duodenoscope, 27 new infections were found.

All of their reprocessing steps were done correctly, yet they couldn’t stop the outbreaks, says Ofstead. In the end, they changed their process to ethylene-oxide gas sterilization instead of automated high-level disinfection. No new cases have been identified since changing to gas sterilization.

 

Safety challenges remain

Infection control has always been a high-risk topic for the Joint Commission, notes John Eiland, MS, RN, former surveyor for the Joint Commission and senior research associate at Ofstead & Associates, Inc. Nearly half (46%) of all hospitals surveyed in 2013 had an infection control finding, he says.

More disturbing, over half of the most serious observations—ie, those with immediate threat to life—were directly related to sterilization and high-level disinfection. Endoscopy has been one of the top 10 observations by the Joint Commission for 4 or 5 straight years, he says.

On March 26, the Joint Commission posted on its website a Quick Safety issue titled: Superbug reveals challenges with high-level disinfection. In it, the Joint Commission says variation in staff competency, training, and compliance contribute to CRE and that it continues to find noncompliance at accredited hospitals and ambulatory surgery facilities. The Joint Commission listed 15 safety actions to consider, including:

• following evidence-based guidelines for high-level disinfection reprocessing

• following IFUs and ensuring they are updated, available, and user-friendly

• ensuring staff are competent and trained in high-level disinfection processes, including managers and supervisors with oversight responsibilities

• following FDA Safety Communication recommendations

• following a verification process to ensure the endoscopes are free of infectious materials (ie, swabbing endoscopes to confirm no growth in cultures).

Inadequate reprocessing of endoscopes and surgical instruments was number four on the ECRI Institute’s Top 10 Health Technology Hazards for 2015.

Among the recommendations:

• emphasizing to reprocessing staff and end users that endoscopes must be thoroughly cleaned before they can be disinfected or sterilized

• confirming that an appropriate reprocessing protocol exists and is readily available

• providing adequate training on endoscope cleaning and reprocessing when staff are hired and when new devices are put into service

• monitoring adherence to protocols and quality of endoscope cleaning.

On March 3, ECRI Institute posted a High Priority Hazard Report recommending culturing duodenoscopes as a key step to reducing CRE infections. ECRI Institute also provides a free CRE and duodenoscope resource center on its website that includes the latest guidance and recommendations for prevention, with a focus on technology management, risk management, and patient safety.


Endoscope reprocessing steps

Eight steps are involved in endoscope reprocessing, and there are multiple components under each step that require critical thought processes during which staff can deviate or skip or minimize how they are going to take care of that endoscope.

Precleaning. Precleaning should be performed at the point of use before bioburden has a chance to dry and before decontamination. Precleaning at the point of use is where 99.9% of organisms are removed, says Catherine K. Rocco, MSN, RN, CNOR, senior research associate, Ofstead & Associates, Inc, St Paul, Minnesota. If an instrument is not clean, it cannot be high-level disinfected or sterilized. Auxiliary water channels and air-water channels need to be flushed whether they were used or not.

Leak testing. Leak testing detects damage to the interior or exterior of the endoscope. It is done before immersion of the endoscope in reprocessing solutions.

Leak testing steps have to be done in a specific order, notes Lynne Thomas, BSN, RN, CGRN, CFER, vice president of regulation and compliance, Integrated Medical Systems, Inc, Birmingham, Alabama. For example, the leak tester has to be attached and the endoscope pressurized before it is immersed in water.

To save time, staff sometimes immerse endoscopes before they are pressurized. When this is done, a leak won’t be seen because fluid has already entered the scope. Another problem comes with not immersing the endoscope long enough for bubbles from small, slow leaks to come out.
In addition to manual leak testing, there is also computerized leak testing in which the leak tester is attached to a computer.

Manual cleaning. Manual cleaning is done in the decontamination room or sterile processing to remove microbial burden from the endoscope. Manufacturer’s instructions for use (IFU) for enzymatic detergents should be followed closely. Brushing and rinsing is essential and needs to be aggressive. This should be done within 1 hour after the procedure, and the time when the procedure was finished needs to be tracked and reported, advises Thomas.

It is also important to remember that the enzymatic detergent cleaning solution is not a disinfectant, says Rocco. It does not kill microbes. It only facilitates the cleaning process. In addition, the enzymatic detergent has to be used at the right concentration and fresh solution used for each endoscope.

Rinse after manual cleaning. After manual cleaning, the endoscope and all removable parts are thoroughly rinsed with clean water to remove residual debris and detergent. Rinse water is purged from channels using forced air, and the exterior is dried with a soft, lint-free cloth.

High-level disinfection or sterilization. High-level disinfection is recognized as the standard for reprocessing endoscopes. High-level disinfection destroys all viable microorganisms, but not necessarily all bacterial spores. High-level disinfection can be done manually or with an automated endoscope reprocessor. Sterilization of endoscopes is indicated when they are used as critical devices, and there is potential for contamination of an open surgical field.

Rinse after manual high-level disinfection. After manual high-level disinfection, all endoscope surfaces, removable parts, and channels are rinsed with clean water.

Drying. After rinsing, all endoscope channels are purged with air until dry, flushed with alcohol, and purged again with air. The alcohol aides in removing residual water as it flows through the channel.

The amount of air used to purge should not exceed 29 psi for small-diameter endoscopes or 71 psi for larger-diameter endoscopes, says Thomas. If it is higher, there is the potential to break down the o-rings and seals. If that occurs, it creates an avenue for microorganisms and liquids to enter the internal parts of the endoscopes.

The exterior of the endoscope is dried with a soft, clean lint-free towel, as are all removable parts. Removable parts are not attached during storage.
If a final alcohol rinse cycle is not included in the automated reprocessor cycle, this step should be done manually.
Storage. Endoscopes should be stored in a manner that will protect them from contamination. They should not be stored in shipping containers or in drawers, says Rocco.

Hanging endoscopes in a vertical position in a clean, well-ventilated, and dust-free storage area discourages microbial contamination. Guidelines on hang time for endoscopes differ: AORN says flexible endoscopes should be reprocessed before use if unused for more than 5 days, the Association for Professionals in Infection Control and Epidemiology says 7 days, Multisociety guidelines say 10 to 14 days, and the Society of Gastroenterology Nurses and Associates doesn’t specify a time.


Guideline updates in response to superbug outbreaks

Based on the outbreaks, associations as well as regulatory and epidemiology groups have had varied responses, says Lynne Thomas, BSN, RN, CGRN, CFER, vice president of regulation and compliance, Integrated Medical Systems, Inc, Birmingham, Alabama.
•    The American Society for Gastrointestinal Endoscopy (ASGE) and Society of Gastroenterology Nurses and Associates (SGNA) are discussing the monitoring of effective reprocessing.
•    The Association for Professionals in Infection Control and Epidemiology (APIC) and Society for Healthcare Epidemiology of American (SHEA) are considering a move toward sterilization and not using high-level disinfection.
•    The Association for the Advancement of Medical Instrumentation (AAMI) Standard 91—Comprehensive guide to flexible and semi-rigid endoscope reprocessing in health care facilities—which is in development, recommends sterilization rather than high-level disinfection, if possible. It also discusses establishing monitors of key cleaning parameters, markers for organic soil, and documentation of processes along the utilization cycle.
•    AORN is updating its guidelines that were first published in 2009. The guidelines are in peer review and should be out by the end of the year.
•    The Centers for Disease Control and Prevention (CDC) is concentrating on inadequate device processing, and it is considering microbial sampling of endoscopes. The organization has published protocols for hospitals that want to culture endoscopes between cases, but it is not yet ready to make a blanket recommendation.
•    The Food and Drug Administration (FDA) is focusing on the design of the device and validation of reprocessing instructions for use.
•    The Multisociety guideline on reprocessing flexible gastrointestinal endoscopes was revised in 2011. Its recommendations complement guidelines from professional organizations. However, the guideline has unresolved issues, including interval of endoscope storage after reprocessing, frequency of replacing water bottles and associated tubing, waste vacuum canisters and their associated tubing, microbial surveillance, and integration of new technologies for some of the automated systems.

 

References

Centers for Disease Control and Prevention. Interim duodenoscope surveillance protocol. http://www.cdc.gov/hai/organisms/cre/cre-duodenoscope-surveillance-protocol.html.

Centers for Disease Control and Prevention. Notes from the field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography—Illinois, 2013. Morbidity and Mortality Weekly Report. January 3, 2014;62(51):1051. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6251a4.htm.

ECRI Institute. CRE and duodenoscope resource center. https://www.ecri.org/resource-center/Pages/Superbug.aspx?cm_mid=4513568&cm_crmid=4e1e57bb-a03c-e111-863d-005056930045&cm_medium=email.

ECRI Institute. High priority hazard report: ECRI Institute recommends culturing duodenoscopes as a key step to reducing CRE infections. https://www.ecri.org/Resources/Superbug/Culturing_Duodenoscopes_Key_Step_to_Reducing_CRE_Infections.pdf?cm_mid=4513568&cm_crmid=4e1e57bb-a03c-e111-863d-005056930045&cm_medium=email.

ECRI Institute. Top 10 Health Technology Hazards for 2015. https://www.ecri.org/press/Pages/ECRI-Institute-Announces-Top-10-Health-Technology-Hazards-for-2015.aspx.

Food and Drug Administration. Reprocessing medical devices in health care settings: Validation methods and labeling. March 17, 2015. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm437971.htm.

Food and Drug Administration. Safety Communication: Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. March 4, 2015. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm434871.htm.

Joint Commission. Quick Safety issue: Superbug reveals challenges with high-level disinfection. March 26, 2015. http://www.jointcommission.org/issues/article.aspx?Article=u2mp75tAioASPIorhd8t5VWpLyAoBDGSdGXN%2bdTvch0%3d&j=2472355&e=jmathias@ormanager.com&l=9552_HTML&u=44856824&mid=1064717&jb=0.

Kobaleva J, Peters F, van der Mei H, et al. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231-254.

Ofstead C, Dirlam Langlay A, Mueller N, et al. Re-evaluating endoscopy-associated infection risk estimates and their implications. Am J Infect Control. 2013;41(8):734-736.

Ofstead C, Rocco C, Eiland J. Effective endoscope reprocessing in a time of uncertainty. AORN Surgical Conference & Expo 2015.

Schembre D. Infectious complications associated with gastrointestinal endoscopy. Gastrointest Endosc Clin N Am. 2000;10:215-232.

Spach D, Silverstein F, Stamm W. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med. 1993;118:117-128.

Thomas L A. Flexible scopes, rigid rules. AORN Surgical Conference & Expo 2015.

Tozzi J. Can anything kill the deadly bacteria on endoscopes? Bloomberg Business. April 1, 2015. http://www.bloomberg.com/news/articles/2015-04-01/bacteria-lingers-on-medical-scopes-even-with-heightened-cleaning.

Visrodia K H, Ofstead C L, Yellin H L, et al. The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol. 2014;35(8):987-994.

Wendorf K, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli. Infect Control Hosp Epidemiol. Published online March 30, 2015. http://journals.cambridge.org/download.php?file=%2F6644_327D30D90776C93A9807232CB5F1B2DF_journals__ICE_S0899823X15000665a.pdf&cover=Y&code=4ca941ed0cea66fc5eecd461067b11c3.

Join our community

Learn More
Video Spotlight
Live chat by BoldChat